Dr. Linden et Vs. Seybold, Spinal neurokinin(3) receptors mediate thermal but not mechanical hyperalgesia via nitric oxide, PAIN, 80(1-2), 1999, pp. 309-317
Although intrathecally administered senktide, an agonist at the neurokinin(
3) receptor, attenuates withdrawal responses to noxious stimuli in the rest
rained animal, senktide increases motor neuron activity in spinal cords of
neonatal rats and facilitates the electrically-evoked nociceptive flexor re
flex in the adult rat. The present study examined the effects of intratheca
l administration of senktide on withdrawal responses ro noxious thermal and
mechanical stimuli in awake, unrestrained, adult rats. Intrathecal adminis
tration of senktide (10 nmol) in chronically catheterized rats did not alte
r the responses elicited by a noxious mechanical stimulus (508 mN, von Frey
monofilament). Conversely, intrathecal senktide (10 nmol) induced thermal
hyperalgesia, indicated by decreased withdrawal latency to radiant heat. Th
ermal hyperalgesia peaked 20-26 min following drug injection and returned t
o normal within 30 min. SR 142801 (60 nmol), a nonpeptide neurokinin(3) rec
eptor antagonist, inhibited the senktide-induced hyperalgesia, providing fu
rther support that the effect of senktide is mediated by neurokinin3 recept
ors. Pretreatment with NG-nitro-L-arginine methyl ester (30 nmol), a nitric
oxide synthase inhibitor, blocked the effect of senktide, indicating that
senktide-induced thermal hyperalgesia is also mediated by the production of
nitric oxide. Intrathecal senktide produced vasodilation and increased ski
n temperature in the hind paw. Intravenous hexamethonium, a ganglionic nico
tinic receptor antagonist, similarly increased paw temperature without decr
easing withdrawal latency to radiant heat. Thus, the increased skin tempera
ture associated with intrathecal senktide was insufficient to account for t
he thermal hyperalgesia observed. Collectively, the present work demonstrat
es that NK3 receptors mediate thermal but not mechanical hyperalgesia throu
gh a pathway that involves the production of NO. (C) 1999 International Ass
ociation for the Study of Pain. Published by Elsevier Science B.V.